Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC in Recurrent Implantation Failure
NCT03862586Phase 3Completed
- Sponsor
- Royan Institute
- Start
- Feb 2015
- Primary completion
- May 2017
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in Recurrent Implantation Failure (RIF) comparing N-acetyl cysteine with Placebo (2 arms). Primary endpoint: Expression of HOXA in endometrium. Started Feb 2015; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Recurrent Implantation Failure (RIF)
Beyond the preview
Go deeper on NCT03862586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03862586.